These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24922157)

  • 21. Moving toward tuberculosis elimination: implementation of statewide targeted tuberculin testing in Tennessee.
    Cain KP; Garman KN; Laserson KF; Ferrousier-Davis OP; Miranda AG; Wells CD; Haley CA
    Am J Respir Crit Care Med; 2012 Aug; 186(3):273-9. PubMed ID: 22561962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of tuberculosis in migrant children in Switzerland and relevance of current screening guidelines.
    Boukamel M; Fougère Y; Gehri M; Suris JC; Rochat I; Miletto D; Kyrilli S; Fouriki A; Crisinel PA
    Swiss Med Wkly; 2020 Jun; 150():w20253. PubMed ID: 32557426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
    Gran G; Aßmus J; Dyrhol-Riise AM
    BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening and Treatment Rates for Latent Tuberculosis Among Newly-Arrived Refugees in an Urban Facility in Connecticut.
    Duchen D; Boyd AT; Annamalai A
    Conn Med; 2017 May; 81(5):291-298. PubMed ID: 29738131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of tuberculosis screening for migrant children in a low-incidence country.
    Usemann J; Ledergerber M; Fink G; Ritz N
    Int J Tuberc Lung Dis; 2019 May; 23(5):579-586. PubMed ID: 31097066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
    Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA
    Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of latent tuberculosis infection among migrant farmworkers along the US-Mexico border.
    Oren E; Fiero MH; Barrett E; Anderson B; Nuῆez M; Gonzalez-Salazar F
    BMC Infect Dis; 2016 Nov; 16(1):630. PubMed ID: 27809805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Morocco.
    Sabri A; Quistrebert J; Naji Amrani H; Abid A; Zegmout A; Abderrhamani Ghorfi I; Souhi H; Boucaid A; Benali A; Abilkassem R; Kmari M; Hassani A; Lahcen B; Siah S; Schurr E; Boisson-Dupuis S; Casanova JL; Lahlou A; Laatiris A; Louzi L; Ouarssani A; Bourazza A; Aouragh A; Mustapha B; Messaoudi N; Agader A; Cobat A; Abel L; El Baghdadi J
    PLoS One; 2019; 14(8):e0221081. PubMed ID: 31415649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberculin skin test versus interferon-gamma release assay in refugee children: A retrospective cohort study.
    Elliot C; Marais B; Williams P; Joshua P; Towle S; Hart G; Zwi K
    J Paediatr Child Health; 2018 Aug; 54(8):834-839. PubMed ID: 29442397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.
    Ramos JM; Robledano C; Masiá M; Belda S; Padilla S; Rodríguez JC; Gutierrez F
    BMC Infect Dis; 2012 Jul; 12():169. PubMed ID: 22849726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and incidence of latent tuberculosis infection in georgian healthcare workers.
    Whitaker JA; Mirtskhulava V; Kipiani M; Harris DA; Tabagari N; Kempker RR; Blumberg HM
    PLoS One; 2013; 8(3):e58202. PubMed ID: 23536789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Study of Optimal Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Disease.
    Al-Taweel T; Strohl M; Pai M; Martel M; Bessissow T; Bitton A; Seidman E; Afif W
    Dig Dis Sci; 2018 Oct; 63(10):2695-2702. PubMed ID: 29968143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of and risk factors associated with latent tuberculosis in Singapore: A cross-sectional survey.
    Yap P; Tan KHX; Lim WY; Barkham T; Tan LWL; Chen MI; Wang YT; Chee CBE
    Int J Infect Dis; 2018 Jul; 72():55-62. PubMed ID: 29758278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of latent tuberculosis infection and feasibility of TB preventive therapy among Thai prisoners: a cross-sectional study.
    Gatechompol S; Harnpariphan W; Supanan R; Suwanpimolkul G; Sophonphan J; Ubolyam S; Kerr SJ; Avihingsanon A; Kawkitinarong K
    BMC Public Health; 2021 Jun; 21(1):1206. PubMed ID: 34162348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children.
    Laskin BL; Goebel J; Starke JR; Schauer DP; Eckman MH
    Am J Kidney Dis; 2013 Jan; 61(1):22-32. PubMed ID: 22784996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants.
    Orlando G; Merli S; Cordier L; Mazza F; Casazza G; Villa AM; Codecasa L; Negri E; Cargnel A; Ferrarese M; Rizzardini G
    Infection; 2010 Jun; 38(3):195-204. PubMed ID: 20411295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-employment screening of latent tuberculosis infection among healthcare workers using tuberculin skin test and QuantiFERON-TB Gold test at a tertiary care hospital in Saudi Arabia.
    El-Helaly M; Khan W; El-Saed A; Balkhy HH
    J Infect Public Health; 2014; 7(6):481-8. PubMed ID: 25194817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of latent tuberculosis infection with T-SPOT(®).TB in a predominantly immigrant population with rheumatologic disorders.
    Escalante P; Kooda KJ; Khan R; Aye SS; Christianakis S; Arkfeld DG; Ehresmann GR; Kort JJ; Jones BE
    Lung; 2015 Feb; 193(1):3-11. PubMed ID: 25318864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.